Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The prelimbic prefrontal cortex mediates the development of lasting social avoidance as a consequence of social threat conditioning
    Published on 2025-02-26
    1 year ago
  • A projection from the medial prefrontal cortex to the lateral septum modulates coping behavior on the shock-probe test
    Published on 2025-02-26
    1 year ago
  • Pharmacological reduction of reverse-translated hippocampal hyperactivity in mouse: relevance for psychosis
    Published on 2025-02-26
    1 year ago
  • The crosstalk between CREB and PER2 mediates the transition between mania- and depression-like behavior
    Published on 2025-02-26
    1 year ago
  • Longitudinal associations between white matter integrity, early life adversities, and treatment response following cognitive-behavioral therapy in depression
    Published on 2025-02-25
    1 year ago
  • Protein interacting with C-kinase 1 (PICK1) regulates synaptic function and reversal learning in a mouse model for schizophrenia
    Published on 2025-02-21
    1 year ago
  • Prediction of alcohol intake patterns with olfactory and gustatory brain connectivity networks
    Published on 2025-02-16
    1 year ago
« Previous 1 … 61 62 63 64 65 … 143 Next »
Journal of Psychopharmacology
  • Pentoxifylline as adjunctive therapy in cognitive deficits and symptoms of schizophrenia: A randomized double-blind placebo-controlled clinical trial
    Published on 2023-07-19
    3 years ago
  • Modafinil: A closer look at its theoretical toxicological potential
    Published on 2023-07-12
    3 years ago
  • Science, safety and education: Informing the psychedelic treatment of psychiatric disorders
    Published on 2023-07-08
    3 years ago
  • Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review
    Published on 2023-07-05
    3 years ago
  • Oral sodium oxybate does not alter plasma kisspeptin levels in healthy male volunteers
    Published on 2023-07-04
    3 years ago
  • Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice
    Published on 2023-07-03
    3 years ago
  • Psilocybin’s effects on cognition and creativity: A scoping review
    Published on 2023-07-03
    3 years ago
« Previous 1 … 61 62 63 64 65 … 150 Next »
European Neuropsychopharmacology
  • Foundations for safer evidence-based digital health technologies under construction
    Published on 2023-07-14
    3 years ago
  • Neuropsychological functioning of patients with major depression or bipolar disorder comorbid to substance use disorders: A systematic review
    Published on 2023-07-14
    3 years ago
  • Neurochemistry of the antidepressant effect – a misunderstanding?
    Published on 2023-07-14
    3 years ago
  • Smart digital phenotyping
    Published on 2023-07-13
    3 years ago
  • The potential of psychedelics for the treatment of Alzheimer’s disease and related dementias
    Published on 2023-07-13
    3 years ago
  • The clinical high-risk of psychosis approach as an emerging model for precision prevention in psychiatry
    Published on 2023-07-13
    3 years ago
  • Robotics in psychiatry – Fiction or reality. A reply
    Published on 2023-07-07
    3 years ago
« Previous 1 … 61 62 63 64 65 … 168 Next »

   Pharma Pub